ISENTRESS

Details for Australian Trade Mark No. 1131748 (hide)

Owner Merck Sharp & Dohme Corp.

Convention US 21 April 2006 78/866853

Service Shelston IP

Filing Date 24 August 2006

Classes

Class 5 Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system, gastrointestinal diseases and disorders, cancer, obesity, inflammation and inflammatory diseases, respiratory diseases and disorders, musculo-skeletal disorders, osteoporosis, menopausal symptoms and disorders, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations, antiemetic preparations, and vaccine preparations

Event Publications

14 September 2006 Application filed

28 September 2006 Application Accepted

15 February 2007 Trade Mark Registered/Protected

28 January 2010 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp..

26 July 2012 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp..

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1131749-INROCADE

1131747-DIALAMINE